Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWhat the first week actually tells you, and what it doesn't
The myth: week one should show up on the scales
The most persistent misconception about starting Wegovy is that the first seven days will produce visible, scale-confirmed weight loss. It rarely does, and that silence on the scales is not a sign the medicine isn't working. At 0.25mg, semaglutide is occupying GLP-1 receptors in the gut and brain at a low level, enough to begin shifting appetite signals, but not enough to produce the pronounced calorie deficit that drives fat loss over time. The prescription deliberately starts here to reduce the risk of nausea and vomiting that would otherwise make many people stop early.
What the first week is actually measuring is tolerability. Can your digestive system adjust without serious disruption? Does the injection site feel manageable? Those are the questions week one answers. The full picture of how Wegovy works across a full course of treatment puts this early phase in proper context.
Some people do notice a modest drop in the first week, mainly because reduced appetite means they are eating less. That is real, and encouraging, but it is not the same as the sustained fat loss that builds across months of treatment. If the scale moves, that's a bonus. If it doesn't, nothing has gone wrong.
What you will (and may) notice in the first seven days
The signals most people describe in wegovy results week 1 are almost entirely about appetite and digestion rather than weight. A quieter internal monologue around food is common, the persistent background hum of hunger that many people live with simply becomes less insistent. Meals feel satisfying sooner. Snacking between meals may feel less automatic.
Alongside that, GI side effects are the most reported early experience. Nausea is the most frequent, typically mild and often worst in the first couple of days after the injection, easing through the week. Constipation and looser stools are both possible; so is a low-grade feeling of fullness that makes large portions unappealing. The NHS medicines page for semaglutide sets out the full side-effect profile clearly and is worth reading before you start.
Fatigue and mild headache are less common but do occur in early treatment. Staying well hydrated helps, particularly if appetite suppression is making you eat and drink less than usual. These effects typically settle over the first two to four weeks as the body acclimatises.
One thing worth knowing: the day of the week you inject can matter to your day-to-day life in small ways. If you order treatment at the start of the month (payday for many people, or after a bank holiday) injecting on a Monday or Tuesday means any nausea tends to land mid-week when your routine is predictable, rather than over a weekend when plans may already be in place.
How week one fits into the longer treatment arc
The STEP 1 clinical trial, published in the New England Journal of Medicine, measured outcomes across 68 weeks and found participants lost an average of around 15% of body weight on semaglutide 2.4mg. That figure is the product of many months of dose increases, appetite change and behavioural adjustment, not the first pen.
The dose pathway runs from 0.25mg through 0.5mg, 1.0mg and 1.7mg before reaching the 2.4mg maintenance dose, with each step taking roughly a month. Most people start to notice more consistent appetite suppression from around the 0.5mg or 1.0mg stage. Understanding how long Wegovy typically takes to work helps calibrate expectations across those early months.
If you want to track progress in a useful way, weight measured on the same day each week, at the same time of day, gives a more honest trend than daily checks. The number at day seven specifically tends to carry more noise than signal. What matters more is whether appetite is shifting and side effects are manageable, those are the early indicators that the medicine is behaving as intended.
By the four-week mark, a clearer picture emerges for most people, and by eight weeks many are noticing consistent changes in eating habits and a more meaningful shift in weight. Each step along the way has its own character.
When to speak to a prescriber about your first week
Most first-week experiences, even uncomfortable ones, are expected. That said, some symptoms need clinical attention rather than patience. Severe or persistent vomiting that prevents you from staying hydrated, signs of an allergic reaction (rash, facial swelling, difficulty breathing) or intense stomach pain that spreads to your back, these are reasons to seek help promptly, not to wait for next week's injection. The MHRA Yellow Card scheme lets you report any suspected side effect directly to the regulator, which actively monitors GLP-1 medicines.
If your first week has felt fine and you're curious about what comes next, week two and week three tend to be where appetite suppression becomes more noticeable for many people. And if you haven't yet started but are weighing up your options, our prescribers are available to talk through whether Wegovy is clinically appropriate for you.
Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.